Saliva test upstart Rako Science sold to rival APHG

Saliva test upstart Rako Science sold to rival APHG
Rako Science partnered with Waipareira Trust to provide covid saliva testing for Māori. (Image: NZME)
Pattrick Smellie
Today’s announcement of the sale of saliva-testing firm Rako Science to what was once its arch-rival, Asia Pacific Healthcare Group (APHG), is a classic case of the old adage: “If you can’t beat 'em, join 'em”.For more than a year at the height of the covid lockdowns, Rako and APHG were at one another’s throats both in public and behind-the-scenes as Rako aggressively pressed the case for national uptake of its novel saliva test technology.Rako’s main target was the health ministry, which appeared to...

More Opinion

Token-ology: the next thing
Opinion

David Chaplin: Token-ology: the next thing

Despite promising developments, fund tokenisation remains in an experimental phase.

Covid helped polarise us
Opinion

Sir Peter Gluckman: Covid helped polarise us

The pandemic's consequences continue to reverberate. 

Rangatira eyes international stocks
Opinion

Paul McBeth: Rangatira eyes international stocks

The investment firm is finding things tough going for local holdings.

Paul McBeth 10 Dec 2024
Nabers, everybody needs good Nabers
Property Opinion

Maria Slade: Nabers, everybody needs good Nabers

New Zealand is 15 years behind Australia in encouraging green building.

Maria Slade 09 Dec 2024